Catalyst

Slingshot members are tracking this event:

MRK's CETP CV outcomes for hypercholesterolemia expected in Q1 2017

Source Link:
http://www.mercknewsroom.com/news-release/research-and-development-news/merck-provides-update-reveal-outcomes-study

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MRK Community voting in process
AMGN Community voting in process
ESPR Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 27, 2017
Occurred Source:
http://investors.merck.com/news/press-release-details/2017/Merck-Provides-Update-on-REVEAL-Outcomes-Study-of-Anacetrapib/default.aspx
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Cetp Cv, Hypercholesterolemia
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.